Lombard Medical Stock Net Asset

EVARF Stock  USD 0.0001  0.00  0.00%   
Fundamental analysis of Lombard Medical allows traders to better anticipate movements in Lombard Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Lombard Medical Company Net Asset Analysis

Lombard Medical's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

 = 

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current Lombard Medical Net Asset

    
  67.77 M  
Most of Lombard Medical's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lombard Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition

Based on the recorded statements, Lombard Medical has a Net Asset of 67.77 M. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.

Lombard Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lombard Medical's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Lombard Medical could also be used in its relative valuation, which is a method of valuing Lombard Medical by comparing valuation metrics of similar companies.
Lombard Medical is currently under evaluation in net asset category among its peers.

Lombard Fundamentals

About Lombard Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Lombard Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lombard Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lombard Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Lombard Pink Sheet

Lombard Medical financial ratios help investors to determine whether Lombard Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lombard with respect to the benefits of owning Lombard Medical security.